Pharmacokinetics, urinary excretion and plasma protein binding of danofloxacin following intravenous administration in buffalo calves (Bubalus bubalis).
Pharmacokinetics, urinary excretion and plasma protein binding of danofloxacin was investigated in buffalo calves following intravenous administration at the dose rate of 1.25 mg/kg to select the optimal dosage regimen of danofloxacin. Drug concentrations in plasma and urine were measured by microbiological assaying. In vitro plasma protein binding was determined employing the equilibrium dialysis technique. The distribution and elimination of danofloxacin were rapid, as indicated by values (mean +/-SD) of distribution half-life (t(1/2)alpha = 0.16 +/- 0.07 h) and elimination half-life (t(1/2)beta = 4.24 +/- 1.78 h), respectively. Volume of distribution at steady state (Vss) = 3.98 +/- 1.69 L/kg indicated large distribution of drug. The area under plasma drug concentration versus time curve (AUC) was 1.79 +/- 0.28 micrg/ml x h and MRT was 8.64 +/- 0.61 h. Urinary excretion of danofloxacin was 23% within 48 h of its administration. Mean plasma protein binding was 36% at concentrations ranging from 0.0125 microg/ml to 1 microg/ml. On the basis of pharmacokinetic parameters obtained, it is concluded that the revision of danofloxacin dosage regimen in buffalo calves is needed because the current dosage schedule (1.25 mg/kg) is likely to promote resistance.
Sappal
Ravinder
R
College of Veterinary Science, Guru Angad Dev Veterinary and Animal Science University, Ludhiana, 141004, Punjab, India.
Chaudhary
Rakesh Kumar
RK
Sandhu
Harpal Singh
HS
Sidhu
Pritam Kaur
PK
D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D002020:Buffaloes; D024841:Fluoroquinolones / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D007275:Injections, Intravenous; D007700:Kinetics; D008297:Male; D011485:Protein Binding
D001798:Blood Proteins; D024841:Fluoroquinolones; C068581:danofloxacin